Skip to main content

Advertisement

Table 2 Treatment emergent AEs reported in >5% of subjects (3 or more), excluding mild and not related to treatment

From: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Adverse Event # of Subjects
Sedation/Somnolence 18
Depressed Mood 17
Anxiety 13
Insomnia 10
Akathisia 9
Fatigue 7
Agitation 5
Fall 4
Dysphagia 3
Dystonia 3